Vertex Pharmaceuticals (VRTX) Other Working Capital Changes (2009 - 2026)

Vertex Pharmaceuticals' Other Working Capital Changes history runs 18 years deep, the most recent figure standing at -$173.4 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 8.07% year-over-year to $35.7 million in Q1 2019; TTM through Mar 2019 was $74.5 million, a N/A change from a year earlier, with the FY2018 full-year figure at $129.3 million, down 18.69% from the prior year.
• Other Working Capital Changes eased to $35.7 million in Q1 2019 per VRTX's latest filing, from $38.8 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $38.8 million in Q1 2018 and bottomed at $35.7 million in Q1 2019.
• The 5-year median for Other Working Capital Changes is $40.9 million (2025), against an average of $76.2 million.
• Across the five-year window, Other Working Capital Changes soared 1889.31% in 2022 and plunged 717.08% in 2026, its largest moves.
• Year by year, Other Working Capital Changes stood at $38.8 million in 2018, then slipped by 8.07% to $35.7 million in 2019.
• Per Business Quant, the three latest VRTX Other Working Capital Changes figures stand at $35.7 million (Q1 2019), $38.8 million (Q1 2018), and -$204000.0 (Q1 2011).